维普中文期刊产品整合服务
8篇 您的检索式:作者名="LINDHOFER H"
    题名 作者 年代 出处 被引量
1Development and approval of the trifunctional antibody catumaxomab(anti- EpCAM x anti-CD3)as a targeted cancer immunotherapy 显示文摘Seimetz D Lindhofer H Bokemeyer C 2010Cancer Treat Rev2010,36,6:1
2Preferentialspecies-restricted heavy/light chain pairing in rat/mouse quadromas:implications for a single-step purification of bispecific antibodies显示文摘LINDHOFER H MOCIKAT R STEIPE B 1995Journal of Immunology1995,155,1:1
3Influence ofcatumaxomab on tumor cells in bone marrow and blood in ovariancancer显示文摘Wimberger P Heubner M Lindhofer H 2009Anticancer Res2009,29,5:1
4Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lympho- cytes and trifunctional bispecific antibody 显示文摘Morecki S Lindhofer H Yacovlev E 2008Exp Hematol2008,36,8:1
5Development and approval of the trifunctional antibody catumaxomab (anti- EpCAM x anti-CD3 ) as a targeted cancer immunothempy 显示文摘Seimetz D Lindhofer H Bokemeyer C 2010Cancer Treat Rev2010,36,6:1
6Development and approval of the trifunctional antibody eatunaaxomab ( anti-EpCAM _ anti-CD3 ) as a targeted cancer immunotherapy 显示文摘SEIMETZ D LINDHOFER H BOKEMEYER C 2010Cancer Treat Rev2010,36,6:1
7The trifunetional antibody catumaxomab: Correlation between immunologica! response and clinical outcome-New analysis of a pivotal phase Ⅱ/Ⅲstudy 显示文摘OTI' M G LINDHOFER H LINKER G 2010J Clin Oncoi2010,,:1
8Induction of a long-lasting antitumor immunity by a trifunetionai bispecific antibody显示文摘Ruf P Lindhofer H 2001Blood2001,98,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费